Thymol alleviates AGEs-induced podocyte injury by a pleiotropic effect via NF-κB-mediated by RhoA/ROCK signalling pathway

References

• Zhao X, Chen Y, Tan X, et al. Advanced glycation end-products suppress autophagic flux in podocytes by activating mammalian target of rapamycin and inhibiting nuclear translocation of transcription factor EB. J Pathol. 2018;245:235–248.
   PubMed Web of Science ®Google Scholar
• Levin A, Tonelli M, Bonventre J, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017;390:1888–1917.
   PubMed Web of Science ®Google Scholar
• Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med. 2002;346:1145–1151.
   PubMed Web of Science ®Google Scholar
• Yamagishi S, Matsui T. Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid Med Cell Longev. 2010;3:101–108.
   PubMed Web of Science ®Google Scholar
• Busch M, Franke S, Ruster C, et al. Advanced glycation end-products and the kidney. Eur J Clin Invest. 2010;40:742–755.
   PubMed Web of Science ®Google Scholar
• Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care. 1992;15:1835–1843.
   PubMed Web of Science ®Google Scholar
• Ruster C, Bondeva T, Franke S, et al. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes. Nephrol Dial Transplant. 2008;23:2179–2191.
   PubMed Web of Science ®Google Scholar
• Thomas MC, Baynes JW, Thorpe SR, et al. The role of AGE and AGE inhibitors in diabetic cardiovascular disease. Curr Drug Targets. 2005;6:453–474.
   PubMed Web of Science ®Google Scholar
• Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur J Clin Invest. 2004;34:785–796.
   PubMed Web of Science ®Google Scholar
• Yamagishi S, Imaizumi T. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des. 2005;11:2279–2299.
   PubMed Web of Science ®Google Scholar
• Bohlender JM, Franke S, Stein G, et al. Advanced glycation end products and the kidney. Am J Physiol Renal Physiol. 2005;289:F645–F659.
   PubMed Web of Science ®Google Scholar
• Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–820.
   PubMed Web of Science ®Google Scholar
• Vlassara H. The AGE-receptor in the pathogenesis of diabetic complications. Diabetes Metab Res Rev. 2001;17:436–443.
   PubMed Web of Science ®Google Scholar
• Vlassara H, Striker LJ, Teichberg S, et al. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci U S A. 1994;91:11704–11708.
   PubMed Web of Science ®Google Scholar
• Nagoor MM, Javed H, Al TH, et al. Pharmacological properties and molecular mechanisms of thymol: prospects for its therapeutic potential and pharmaceutical development. Front Pharmacol. 2017;8:380.
   PubMed Web of Science ®Google Scholar
• Gholijani N, Gharagozloo M, Farjadian S, et al. Modulatory effects of thymol and carvacrol on inflammatory transcription factors in lipopolysaccharide-treated macrophages. J Immunotoxicol. 2016;13:157–164.
   PubMed Web of Science ®Google Scholar
• Liang D, Li F, Fu Y, et al. Thymol inhibits LPS-stimulated inflammatory response via down-regulation of NF-kappaB and MAPK signaling pathways in mouse mammary epithelial cells. Inflammation. 2014;37:214–222.
   PubMed Web of Science ®Google Scholar
• Wan L, Meng D, Wang H, et al. Preventive and therapeutic effects of thymol in a lipopolysaccharide-induced acute lung injury mice model. Inflammation. 2018;41:183–192.
   PubMed Web of Science ®Google Scholar
• Wu H, Jiang K, Yin N, et al. Thymol mitigates lipopolysaccharide-induced endometritis by regulating the TLR4- and ROS-mediated NF-kappaB signaling pathways. Oncotarget. 2017;8:20042–20055.
   PubMedGoogle Scholar
• Yao L, Hou G, Wang L, et al. Protective effects of thymol on LPS-induced acute lung injury in mice. Microb Pathog. 2018;116:8–12.
   PubMed Web of Science ®Google Scholar
• Wang Q, Cheng F, Xu Y, et al. Thymol alleviates lipopolysaccharide-stimulated inflammatory response via downregulation of RhoA-mediated NF-κB signalling pathway in human peritoneal mesothelial cells. Eur J Pharmacol. 2018;833:210–220.
   PubMed Web of Science ®Google Scholar
• Rask-Madsen C, King GL. Diabetes: podocytes lose their footing. Nature. 2010;468:42–44.
   PubMed Web of Science ®Google Scholar
• Cheng CL, Tang Y, Zheng Z, et al. Advanced glycation end-products activate the renin-angiotensin system through the RAGE/PI3-K signaling pathway in podocytes. Clin Inves Med. Medecine clinique et experimentale. 2012;35:E282.
   PubMed Web of Science ®Google Scholar
• Rao J, Ye Z, Tang H, et al. The RhoA/ROCK pathway ameliorates adhesion and inflammatory infiltration induced by AGE in glomerular endothelial cells. Sci Rep. 2017;7:39727.
   PubMed Web of Science ®Google Scholar
• Makita Z, Radoff S, Rayfield EJ, et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med. 1991;325:836–842.
   PubMed Web of Science ®Google Scholar
• Kumar A, Kujur A, Singh PP, et al. Nanoencapsulated plant-based bioactive formulation against food-borne molds and aflatoxin B1 contamination: preparation, characterization and stability evaluation in the food system. Food Chem. 2019;287:139–150.
   PubMed Web of Science ®Google Scholar
• CHENG C, ZHENG Z, SHI C, et al. Advanced glycation end-products reduce podocyte adhesion by activating the renin-angiotensin system and increasing integrin-linked kinase. Exp Ther Med. 2013;6:1494–1498.
   PubMed Web of Science ®Google Scholar
• Lim AK, Tesch GH. Inflammation in diabetic nephropathy. Mediators Inflamm. 2012;2012:146154.
   PubMed Web of Science ®Google Scholar
• Genuth S, Sun W, Cleary P, et al. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes. 2005;54:3103–3111.
   PubMed Web of Science ®Google Scholar
• Siu B, Saha J, Smoyer WE, et al. Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment. BMC Nephrol. 2006;7:6.
   PubMedGoogle Scholar
• Dai C, Stolz DB, Kiss LP, et al. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol. 2009;20:1997–2008.
   PubMed Web of Science ®Google Scholar
• Zou HH, Yang PP, Huang TL, et al. PLK2 plays an essential role in high D-glucose-induced apoptosis, ROS generation and inflammation in podocytes. Sci Rep. 2017;7:4261.
   PubMed Web of Science ®Google Scholar
• Devuyst O, Margetts PJ, Topley N. The pathophysiology of the peritoneal membrane. J Am Soc Nephrol. 2010;21:1077–1085.
   PubMed Web of Science ®Google Scholar
• Li LM, Hou DX, Guo YL, et al. Role of microRNA-214-targeting phosphatase and tensin homolog in advanced glycation end product-induced apoptosis delay in monocytes. J Immunol. 2011;186:2552–2560.
   PubMed Web of Science ®Google Scholar
• Goolaerts A, Lafargue M, Song Y, et al. PAI-1 is an essential component of the pulmonary host response during pseudomonas aeruginosa pneumonia in mice. Thorax. 2011;66:788–796.
   PubMed Web of Science ®Google Scholar
• Tian L, Li W, Yang L, et al. Cannabinoid receptor 1 participates in liver inflammation by promoting M1 macrophage polarization via RhoA/NF-kappaB p65 and ERK1/2 pathways, respectively, in mouse liver fibrogenesis. Front Immunol. 2017;8:1214.
   PubMed Web of Science ®Google Scholar
• Navarro JF, Mora C, Muros M, et al. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients. Nephrol Dial Transplant. 2006;21:3428–3434.
   PubMed Web of Science ®Google Scholar
• Navarro JF, Milena FJ, Mora C, et al. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration. Am J Nephrol. 2006;26:562–570.
   PubMed Web of Science ®Google Scholar
• Thomson SC, Deng A, Bao D, et al. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest. 2001;107:217–224.
   PubMed Web of Science ®Google Scholar
• Saleem MA, Ni L, Witherden I, et al. Co-localization of nephrin, podocin, and the actin cytoskeleton: evidence for a role in podocyte foot process formation. Am J Pathol. 2002;161:1459–1466.
   PubMed Web of Science ®Google Scholar
• Wang Q, Yang X, Xu Y, et al. RhoA/Rho-kinase triggers epithelial-mesenchymal transition in mesothelial cells and contributes to the pathogenesis of dialysis-related peritoneal fibrosis. Oncotarget. 2018;9:14397.
   PubMedGoogle Scholar
• Uehata M, Ishizaki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997;389:990–994.
   PubMed Web of Science ®Google Scholar